Covid Update, Spring 2021

COVID19 - CORONAVIRUS, 5 Apr 2021

Swiss Policy Research - TRANSCEND Media Service

30 Mar 2021 – An update on virus origin, vaccines, early treatment, masks, long covid, and covid mortality.

A) Facts about covid-19

The fully referenced 20 facts about covid-19 have been updated. In the section below the updated summary, there are 16 updated diagrams, followed by all recent SPR articles on covid-19.

Read more: Facts about covid-19 or in German: Fakten zu Covid-19

B) Origin of SARS-CoV-2

The summary of evidence regarding the origin of the novel coronavirus has also been fully updated. Based on current evidence, the Wuhan Institute of Virology remains the most likely source, but a natural origin or a more complex, geostrategic background cannot be excluded. As in previous pandemics, the WHO is primarily engaged in PR activities.

Read more: On the origin of SARS-CoV-2

C) Vaccines

Real-world studies confirm that vaccine effectiveness in people up to about 70 years is high, but the level of effectiveness in older people remains uncertain. Moreover, neutralization achieved by current mRNA vaccines against the ‘Brazilian’ and ‘South African’ variants is already 10 to 100 times lower; therefore, regular ‘booster shots’ will likely become necessary.

Reported post-vaccination deaths in the USA and Europe are approaching 5000. The real figure may be even higher as there is a substantial reporting backlog. Contrary to media reports, deaths after mRNA vaccines (Pfizer, Moderna) are higher than after AstraZeneca. Dozens of cases of blindness, deafness and miscarriages have also been reported.

US physician J. Patrick Whelan had warned the US FDA already in early December that vaccines based on the coronavirus spike protein may themselves trigger symptoms of severe systemic covid, including blood clots, pulmonary embolism and brain inflammation.

According to New York attorney Aaron Siri, governments and employers are not (yet) permitted to require covid vaccinations, as covid vaccines have not yet been fully authorized: they only received an “emergency use authorization”. For the same reason, health insurers view covid vaccines as “experimental” and may decline cost coverage in case of adverse events.

Read more: Covid vaccines: Post-vaccination deaths and The “Vaccine Passport” Agenda

D) Early treatment

Note: Patients are asked to consult a doctor.

The covid-19 early treatment protocol has been updated and now includes budesonide (a corticosteroid asthma spray) as well as PVI-based mouthwashes and nasal sprays, all of which have been found to be effective against coronavirus infection in several small studies.

In a recent 15-minute testimony, US professor Dr Peter McCullough, lead author of a landmark paper on covid early treatment, emphasized the importance of ambulatory multi-drug treatment in high risk patients to inhibit viral replication, disease progression, and severe covid complications. The late-treatment strategy adopted in many Western countries (“therapeutic nihilism”) may have been one of the most consequential mistakes of the entire pandemic.

Indeed, even the very expensive monoclonal antibodies were found to be totally ineffective in hospitalized patients, but highly effective in early treatment. However, some monoclonal antibodies have already lost their effectiveness against some of the new coronavirus variants.

Read more: On the Treatment of Covid-19

E) Long covid

According to the latest, most solid studies, about 2% to 10% of people report post-acute symptoms lasting longer than three months. The good news is that myocarditis (inflammation of the heart muscle) is less common than initially assumed. Unfortunately, many long covid studies lack PCR or antibody confirmation, a control group, and a symptom severity score.

Read more: On post-acute covid (“long covid”)

F) Masks

The fact that masks don’t work against influenza-like pandemics has been known since the “Spanish flu” in 1918/19, and has been confirmed many times since. However, the coronavirus pandemic for the first time has shown that even FFP2/N95 respirator mandates make no difference at all:

Covid cases in Bavaria (FFP2/N95 mandate) vs. Germany overall (DaFeid/ARD/RKI)

G) Global covid lethality and mortality

By the end of March 2021, there were close to 3 million covid deaths in close to 8 billion people. At a global infection attack rate of 10% to 30%, this results in an average global covid lethality (IFR) of 0.1% to 0.35% and a global covid mortality of about 0.035%.

By comparison, the 1918 flu pandemic had a global mortality of about 2.3% (40 million deaths in 1.8 billion people). In sub-Saharan Africa in 2020, tuberculosis and malaria alone each (!) claimed fifty to a hundred times more years of life than covid-19.

In Western countries, corona lethality is higher than the global average, but nursing homes, while representing only about 1% of the population, account for about 50% of deaths. Thus, IFRs in the non-nursing home population typically range between 0.3% and 0.6%.

Read more: Covid mortality: a global overview and Covid vs. the flu, revisited

Belgium: Covid IFRs in the entire population vs. non-nursing home population. (Molenberghs)2

__________________________________________

Swiss Policy Research, founded in 2016, is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics that for personal and professional reasons prefer to protect their identities, and receives no external funding; there are no financial sponsors or backers. Our articles have been published or shared by numerous independent media outlets and journalists, among them Julian Assange, and have been translated into more than two dozen languages.

Go to Original – swprs.org

Share this article: email mastodon facebook 🔗 copy link

DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.

One Response to “Covid Update, Spring 2021”

1. Andy Hoffman says:

   6 Apr 2021 at 02:25

   Actually there is good date regarding vaccine efficacy in adults over 70. Don’t believe everything you read in Transcend!!

   According to an analysis of the Moderna vaccine trial in the New England Journal of Medicine, patients 18 to 65 years showed an efficacy of 95.6%, while the rate was 86.4% for those older than 65 years. Pfizer, on the other hand, reported that efficacy was over 94% in individuals older than 65 years of age.
   https://www.sfchronicle.com/bayarea/pandemicproblems/article/Is-the-COVID-vaccine-less-effective-in-older-15868931.php